Search results
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 11 hours agoWill this be enough to launch the stock to $95 within a year? That's harder to predict. ...a share...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool via AOL· 2 days agoNonetheless, this value stock pays a healthy dividend today, so there's a basis for immediate and...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 days agoInvestors with cash to spare may also want to start or add to a position in this beauty stock....
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 10 hours agoVertex is the leader in cystic fibrosis drugs, and is testing a treatment for alpha-1 antitrypsin...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 7 days agoArista Networks, Toast and Vertex Pharmaceuticals broke out or flashed buy signals on earnings....
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 6 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
Remembering Quant King Jim Simons
GuruFocus.com via Yahoo Finance· 2 days agoHaving owned the stock for more than a decade, the Danish pharmaceutical company, which is known for its diabetes, obesity, hemophilia...appears to have...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo Finance· 6 days agoprice-consensus-eps-surprise-chart | Editas Medicine, Inc. ...Hold). Some top-ranked stocks in the...